NCT05500053 is a clinical trial in Genital Herpes, sponsored by Rational Vaccines Inc.

Who is sponsoring NCT05500053?

NCT05500053 is sponsored by Rational Vaccines Inc.

What condition does NCT05500053 study?

NCT05500053 studies Genital Herpes, Patient Engagement.

Is NCT05500053 still recruiting?

NCT05500053 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT05500053

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Completed Last updated 18 January 2023

What this trial tests

trial in Genital Herpes in 68 participants. Completed in 31 December 2022.

Timeline

3 August 2022

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Rational Vaccines Inc
Status	Completed
Study type	OBSERVATIONAL
Enrollment	68
Start date	3 August 2022
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across United Kingdom

Conditions studied

Genital Herpes — all drugs for Genital Herpes →
Patient Engagement — all drugs for Patient Engagement →

Sponsor

Rational Vaccines Inc

Who can join

Adults 18 to 64, any sex, with Genital Herpes or Patient Engagement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine the baseline characteristics of patients who have recurrent symptomatic genital herpetic disease Determine the acceptance to patients of clinical trial procedures Determine interest in participation in genital herpes vaccine trials

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.
Duarte LF, Carbone-Schellman J, Bueno SM, Kalergis AM, et al · · 2025 · cited 4× · PMID 39982077 · DOI 10.1128/cmr.00147-24

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05500053 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rational Vaccines Inc
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05500053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing